Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate.

L W Moreland; P W Pratt; M D Mayes; A Postlethwaite; M H Weisman; T Schnitzer; R Lightfoot; L Calabrese; D J Zelinger; J N Woody

doi:10.1002/art.1780381109

Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate.

Identifier:nobleid.org/w1/20260515/AC400CD5

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AC400CD5.svg?ark=w1%2F20260515%2FAC400CD5)](https://nobleid.org/work/w1/20260515/AC400CD5)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate.

Identifier:nobleid.org/w1/20260515/AC400CD5

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AC400CD5.svg?ark=w1%2F20260515%2FAC400CD5)](https://nobleid.org/work/w1/20260515/AC400CD5)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work